Antlia Bioscience, Inc.
PrivateLast Round
Seed Round
Jun 5, 2026
Total Funding Raised
$1.21M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Antlia Bioscience, Inc. is a biopharmaceutical company that develops peptide-based therapies for the treatment of cardiovascular and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antlia Bioscience, Inc. Comparables
Compare Antlia Bioscience, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XL-protein | 76% | |
| Sanofi | 75% | |
| Vasa Therapeutics | 74% |
Antlia Bioscience, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 5, 2026 | ||||
| VC Round | Apr 25, 2022 | ||||
| Seed | Oct 23, 2020 |
Antlia Bioscience, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2026
Raised $6M in a Seed Round.
- Oct 30, 2024
Monthly visitors grew 283% MoM, from 135 to 517.
Antlia Bioscience, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Antlia Bioscience, Inc.'s valuation, stock price, and market status.
Is Antlia Bioscience, Inc. a public or private company?
Antlia Bioscience, Inc. is a private company.
What is the current stock price of Antlia Bioscience, Inc.?
Antlia Bioscience, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Antlia Bioscience, Inc. worth (valuation)?
Valuation information for Antlia Bioscience, Inc. is not publicly available.
Can I buy Antlia Bioscience, Inc. stock?
Antlia Bioscience, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Antlia Bioscience, Inc.'s last funding round?
Antlia Bioscience, Inc.'s most recent funding round was Seed Round on June 5, 2026.
Who are the main investors in Antlia Bioscience, Inc.?
Investor information for Antlia Bioscience, Inc. is not publicly disclosed.
Will Antlia Bioscience, Inc. IPO soon?
No public IPO plans have been announced for Antlia Bioscience, Inc..
How can I track Antlia Bioscience, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Antlia Bioscience, Inc.'s secondary market activity and sign up for updates.